I

    Innoviva Inc (INVA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $20.77
    -0.20 (-0.95%)

    Market Cap: $1.51B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    48%(19/40)
    Avg Surprise
    +202.38%
    Streak
    5 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.46
    Range$0.46 - $0.46
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$0.46+0.0%
    60d ago$0.46+0.0%
    30d ago$0.46+0.0%
    7d ago$0.46+0.0%
    Current$0.46
    Revenue Consensus
    $114M
    Range$104M - $133M
    5 analysts
    Dec 31, 2026
    EPS Consensus$0.52
    Range$0.52 - $0.52
    1 analysts
    Revenue Consensus
    $120M
    Range$95M - $165M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.52---
    Sep 26EST
    		-$0.46---
    Jun 26
    		$0.59$0.56+5.36%Beat-23.4%
    Mar 26
    		$0.47$0.43+9.30%Beat+163.3%
    Dec 25
    		$1.94$0.57+238.68%Beat+647.7%
    Sep 25
    		$1.08$0.46+134.78%Beat+800.0%
    Jun 25
    		$0.77$0.50+54.00%Beat+240.0%
    Mar 25
    		$-0.74$0.33-325.12%Miss-261.5%
    Dec 24
    		$0.26$0.41-36.59%Miss-65.8%
    Sep 24
    		$0.12N/A-55.56%Miss-33.3%
    Jun 24
    		$-0.55$0.24-329.17%Miss-2850.0%
    Mar 24
    		$0.46$0.17+170.59%Beat+9.5%
    Dec 23
    		$0.76$0.23+230.43%Beat+177.6%
    Sep 23
    		$0.18$0.27-33.33%Miss-66.7%
    Jun 23
    		$0.02N/A-92.31%Miss-96.8%
    Mar 23
    		$0.42$0.23+82.61%Beat-4.5%
    Dec 22
    		$-0.98$0.23-526.09%Miss-800.0%
    Sep 22
    		$0.54N/A-75.89%Miss-40.0%
    Jun 22
    		$0.62$0.44+40.91%Beat-31.1%
    Mar 22
    		$0.44$0.48-8.33%Miss-47.6%
    Dec 21
    		$0.14N/A-65.85%Miss-74.5%
    Sep 21
    		$0.90$0.43+109.30%Beat+95.7%
    Jun 21
    		$0.90$0.29+210.34%Beat+172.7%
    Mar 21
    		$0.84$-0.01+8500.00%Beat+100.0%
    Dec 20
    		$0.55$0.40+37.50%Beat+31.0%
    Sep 20
    		$0.46$0.42+9.52%Beat+27.8%
    Jun 20
    		$0.33$0.32+3.13%Beat-2.9%
    Mar 20
    		$0.42$0.36+16.67%Beat+35.5%
    Dec 19
    		$0.42$0.50-16.00%Miss-30.0%
    Sep 19
    		$0.36$0.37-2.70%Miss-18.2%
    Jun 19
    		$0.34$0.42-19.05%Miss-30.6%
    Mar 19
    		$0.31$0.36-13.89%Miss+14.8%
    Dec 18
    		$0.60$0.65-7.69%Miss+25.0%
    Sep 18
    		$0.44$0.42+4.76%Beat+57.1%
    Jun 18
    		$0.49$0.55-10.91%Miss+63.3%
    Mar 18
    		$0.27$0.53-49.06%Miss+80.0%
    Dec 17
    		$0.48$0.49-2.04%Miss+118.2%
    Sep 17
    		$0.28$0.33-15.15%Miss+115.4%
    Jun 17
    		$0.30$0.29+3.45%Beat-
    Mar 17
    		$0.15$0.28-46.43%Miss-
    Dec 16
    		$0.22$0.22+0.00%Beat-
    Sep 16
    		$0.13$0.20-35.00%Miss-

    Dividends

    Dividend Metrics

    Yield0.00%
    Annual/Share$0.00
    Payout Ratio0.00%
    No dividend payments in the selected period.

    Key Metrics

    Valuation
    P/E Ratio5.09EV/EBITDA2.60x
    Price/FCF8.05xFCF Yield12.42%
    Profitability
    Profit Margin81.20%Operating Margin43.30%
    ROE36.70%ROIC13.69%
    Financial Health
    Debt/Equity0.21xInterest Coverage13.15x
    Current Ratio16.01xQuick Ratio15.18x
    Trading Statistics
    Beta0.34Avg Volume672.04K
    52-Week High$25.1452-Week Low$16.52

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$21.09
    SMA 20$20.95
    SMA 50$21.63
    SMA 200$21.80
    EMA 10$21.01
    EMA 20$21.08
    EMA 50$21.45
    EMA 200$21.46

    MACD

    Line: -0.13Signal: -0.16Hist: 0.03

    ADX

    ADX: 10.1+DI: 17.6-DI: 17.6

    Aroon & PSAR

    Aroon Up32.0
    Aroon Down36.0
    PSAR$21.57

    Bollinger Bands

    Upper Band$21.46
    Lower Band$20.45
    %B Position482%(Upper)
    Band Width0.32

    RSI (14-Day)

    Neutral
    43.1

    Momentum Oscillators

    Stoch %K32.4
    Stoch %D45.8
    Williams %R-83.7
    ROC (10d)-0.9%
    Momentum-0.19
    CCI (20d)-46.1
    MFI (14d)40.7

    Volatility Measures

    ATR (14d)$0.47(2.2%)
    StdDev (20d)0.25
    Hist Vol22.4%(Moderate)

    Volume Flow

    VWAP$20.83
    OBV12.2M
    AD Line-6.9M
    CMF (20d)-0.078

    Volume Metrics

    Avg Vol (20d)665.7K
    Vol Ratio1.3x
    VWMA (20d)$20.92

    Pivot Points

    R3$21.36
    R2$21.22
    R1$21.09
    Pivot Point$20.95
    S1$20.82
    S2$20.68
    S3$20.55

    Advanced Oscillators

    TSI-7.75
    Ultimate Osc53.0
    KST-21.03

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$119.59M$97.99M$114.61M$107.80M$100.28M$88.63M$91.81M$89.51M$99.90M$77.50M$85.84M$67.26M
    Cost of Revenue$28.98M$22.16M$38.95M$32.26M$17.14M$15.32M$13.68M$16.50M$14.91M$17.41M$34.91M$10.18M
    Gross Profit$90.62M$75.83M$75.67M$75.54M$83.15M$73.31M$78.13M$73.01M$84.99M$60.09M$50.93M$57.08M
    Operating Expenses$39.76M$37.68M$36.68M$40.96M$34.40M$31.89M$34.99M$29.77M$30.30M$34.28M$76.40M$-30,204,000
    R&D$5.19M$5.24M$4.55M$13.67M$7.98M$4.40M$3.67M$3.55M$2.56M$3.88M$2.36M$3.99M
    SG&A$34.57M$32.44M$32.12M$27.29M$26.41M$27.49M$31.33M$26.22M$27.74M$30.41M$26.32M$28.64M
    Operating Income$50.85M$38.15M$38.99M$34.58M$48.75M$41.43M$43.14M$43.24M$54.69M$25.80M$-25,474,000$87.28M
    Interest Income$-124,235,000$168.64M$117.30M$36.22M$18.01M$-9,011,000$-15,488,000$-12,731,000$-56,634,000$39.74M$82.18M$4.11M
    Interest Expense$5.47M$5.44M$3.31M$4.01M$4.66M$4.71M$4.75M$5.81M$5.80M$5.85M$5.95M$4.40M
    Income Before Tax$-108,020,000$234.56M$195.04M$97.82M$72.60M$-38,589,000$24.69M$6.85M$-39,279,000$45.12M$61.20M$85.95M
    Income Tax Expense$-24,600,000$47.97M$30.88M$7.91M$8.91M$8.00M$4.36M$5.64M$-4,594,000$8.59M$-330,000$3.91M
    Net Income$-83,420,000$186.59M$164.15M$89.91M$63.69M$-46,584,000$20.33M$1.21M$-34,685,000$36.53M$61.53M$82.05M
    EBITDA$32.20M$81.77M$91.52M$76.17M$69.83M$-14,363,000$55.46M$35.91M$33.60M$21.71M$-4,515,000$96.75M
    EBIT$21.69M$71.36M$81.05M$65.61M$59.25M$-24,867,000$44.93M$25.39M$23.16M$11.23M$-15,025,000$86.23M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about INVA

    News

    Innoviva (NASDAQ: INVA) CFO now holds 88,013 shares after tax withholding

    Innoviva's CFO, Stephen Basso, now holds 88,013 shares of common stock after 558 shares were withheld for income tax obligations related to the quarterly vesting of employee equity awards. The shares were disposed of at $21.00 each on August 20, 2026, as detailed in a Form 4 SEC filing. This transaction was not an open-market sale but a tax-related withholding.

    Stock Titan•8/24/26•
    Neutral

    Innoviva (NASDAQ: INVA) CEO sees 1,130 shares withheld for taxes

    Innoviva, Inc. (NASDAQ: INVA) CEO Pavel Raifeld had 1,130 shares of common stock withheld on August 20, 2026, to cover income tax withholding obligations from vested equity awards. This transaction, reported on a Form 4 filing, involved shares valued at $21.00 each. Following this disposition, Raifeld directly owns 284,799 Innoviva common shares.

    Stock Titan•8/24/26•
    Neutral

    Innoviva CEO Pavel Raifeld Executes Tax-Related Share Withholding Transaction

    Innoviva CEO and Director Pavel Raifeld executed a tax-related share withholding transaction on August 20, 2026. This involved the disposition of 1,130 shares of common stock at $21 per share to cover income tax obligations from vested employee equity awards. Following this transaction, Raifeld directly beneficially owns 284,799 shares of Innoviva, Inc. common stock.

    Kalkine Media•8/24/26•
    Neutral

    Cantor Fitzgerald reiterates Innoviva stock rating at overweight

    Cantor Fitzgerald has reiterated an overweight rating for Innoviva Technology, Inc. with a $34 price target, noting the company's successful evolution into a diversified biopharma with strong commercial growth and strategic healthcare assets. Innoviva shows profitable growth with a 50%+ CAGR, an undervalued stock based on a low P/E ratio and InvestingPro analysis, and a strong balance sheet with more cash than debt. Recent developments include exceeding revenue forecasts, launching a new subsidiary for drug delivery, and securing international distribution agreements.

    Investing.com•8/21/26•
    Bullish

    NewEdge Wealth LLC Acquires New Stake in Innoviva, Inc. $INVA

    NewEdge Wealth LLC has acquired a new stake in Innoviva, Inc. (NASDAQ:INVA) during the second quarter, purchasing 99,367 shares valued at approximately $2.26 million. This move makes NewEdge Wealth LLC own about 0.13% of the biotechnology company, while institutional investors collectively hold 99.12% of Innoviva. Analyst sentiment is mixed, with a consensus "Hold" rating and an average price target of $34.75, despite the company's shares opening at $21.00 with a market capitalization of $1.52 billion.

    MarketBeat•8/21/26•
    Neutral

    Frequently Asked Questions About INVA

    Does INVA pay dividends?
    Innoviva Inc (INVA) has a dividend payment track record. See the INVA dividend history page for its current payment status, yield, and streaks.
    What is INVA's P/E ratio?
    Innoviva Inc has a price-to-earnings (P/E) ratio of 5.09.
    What is INVA's market cap?
    Innoviva Inc (INVA) has a market capitalization of $1.51B with a current stock price of $20.77.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In